Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Allison W. Kurian(Stanford University), James M. Ford(Stanford University), Alice S. Whittemore(Cancer Registry of Norway), Kerry Kingham(Cargill (Netherlands)), Stephen E. Lincoln(Whitehead Institute for Biomedical Research), Emily E. Hare(Cargill (Netherlands)), Valerie McGuire(Cargill (Netherlands)), Lisa McPherson(Cargill (Netherlands)), Uri Ladabaum(Stanford University), Yuya Kobayashi(Cargill (Netherlands)), Michele Cargill(Cargill (Netherlands)), Meredith Mills(Cargill (Netherlands))
Cited by 486
Related Papers
MAPMAKER: An interactive computer package for constructing primary genetic linkage maps of experimental and natural populations
|Genomics|1987|6.7k
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862